Assisted Fluid Management Software Guidance for Intraoperative Fluid Administration

Abstract

Background Excessive or inadequate fluid administration causes complications, but despite this, fluid administration during noncardiac surgery is highly variable. Goal-directed management helps optimize the amount and timing of fluid administration; however, implementation is difficult because algorithms are complex. The authors therefore tested the performance of the Acumen Assisted Fluid Management software (Edwards Lifesciences, USA), which is designed to guide optimal intravenous fluid administration during surgery. Methods In this multicenter, prospective, single-arm cohort evaluation, the authors enrolled 330 adults scheduled for moderate- to high-risk noncardiac surgery that required arterial catheter insertion and mechanical ventilation. Clinicians chose a fluid strategy based on a desired 10%, 15%, or 20% increase in stroke volume (SV) in response to a fluid bolus. Dedicated fluid management software prompted “test” or “recommended” boluses, and clinicians were free to initiate a “user” bolus of 100 to 500 ml of crystalloid or colloid. Clinicians were free to accept or decline the software prompts. The authors primarily compared the fraction of software-recommended boluses that produced suitable increases in SV to a 30% reference rate. On an exploratory basis, we compared responses to software-recommended and clinician-initiated boluses. Results Four hundred twenty-four of 479 (89%) software-recommended fluid boluses and 508 of 592 (86%) clinician-initiated fluid boluses were analyzed per protocol. Of those, 66% (95% CI, 62 to 70%) of delivered fluid boluses recommended by the software resulted in desired increases in SV, compared with the 30% reference rate, whereas only 41% (95% CI, 38 to 44%) of clinician-initiated boluses did (P < 0.0001). The mean ± SD increase in SV after boluses recommended by the software was 14.2 ± 13.9% versus 8.3 ± 12.1% (P < 0.0001) for those initiated by clinicians. Conclusions Fluid boluses recommended by the software resulted in desired SV increases more often, and with greater absolute SV increase, than clinician-initiated boluses. Automated assessment of fluid responsiveness may help clinicians optimize intraoperative fluid management during noncardiac surgery. Editor’s Perspective What We Already Know about This Topic What This Article Tells Us That Is New

Perioperative Fluid and Vasopressor Therapy in 2050: From Experimental Medicine to Personalization Through Automation

“…53 In another study that compared manually titrated fluid challenges targeting a stroke volume increase of 10% using the AFM system, stroke volume increased after fluid boluses in 66% of patients in the AFM group but in only 41% of cases in the control group. 54 Once again, this software outperformed experienced clinicians.…”

Control of Postoperative Hypotension Using a Closed-Loop System for Norepinephrine Infusion in Patients After Cardiac Surgery: A Randomized Trial

“…This AFM system makes recommendations about when a bolus of fluid is likely to result in an increase in stroke volume, as described in recent publications. 17–19…”

“…This AFM system makes recommendations about when a bolus of fluid is likely to result in an increase in stroke volume, as described in recent publications. [17][18][19] In all patients, norepinephrine infusion was administered using an electric syringe pump (concentration of 32 µg mL -1 ) on a separate lumen of the central venous catheter during the 2-hour study period to maintain MAP between 65 and 75 mm Hg. In the CLV group, the CLV system adjusted the norepinephrine infusion rate to keep the MAP within this range.…”

Back to the OR of the Future: How Do We Make It a Good One?

“…1 In this issue, the process by which another type of decision support software, Acumen Assisted Fluid Management (Edwards Lifesciences, USA), was approved is presented. 2 The use of artificial intelligence-derived controllers clearly signals a new era in intraoperative hemodynamic management. However, it is troubling to me that neither of these approaches has direct inputs from preoperative patient-specific or other potential anesthetic-specific parameters.…”

“…1 In this issue, the process by which another type of decision support software, Acumen Assisted Fluid Management (Edwards Lifesciences, USA), was approved is presented. 2…”